In 2021, our incredible technical operations teams manufactured more than 72 billion units of medicine for almost a tenth of the world’s population. Despite the ongoing uncertainty of the pandemic, our colleagues have shown remarkable resilience and agility, successfully delivering innovation and excellence for our patients, and collaborating across geographies to bring our life-changing medicines to those in need. Before we jump into 2022 we want to celebrate and recognize their impact. Novartis.com/careers
In 2021, our incredible technical operations teams manufactured more than 72 billion units of medicine for almost a tenth of the world’s population. Despite the ongoing uncertainty of the pandemic, our colleagues have shown remarkable resilience and agility, successfully delivering innovation and excellence for our patients, and collaborating across geographies to bring our life-changing medicines to those in need. Before we jump into 2022 we want to celebrate and recognize their impact. Novartis.com/careers
Novartis is delighted to win the LinkedIn Talent Award 2021 in Switzerland in the categories of Best Culture of Learning and Employee Engagement Champion. While we are happy to celebrate the moment, the journey for us continues. We will continue to create a diverse and inclusive workplace for all associates enabling everyone to be their best selves, encourage personal growth, improve our employee engagement and well-being. We are very excited for 2022! Novartis.com/careers
At Novartis, we are committed to ensuring equity and inclusion for our colleagues with disabilities. We strive to create a shared awareness of what disability is and how we can all contribute to creating a safe and authentic space for open discussion. Increasing accessibility and ensuring all our associates feel equally included is at the heart of our culture. As we mark International Day of Persons with Disabilities our colleague Ciaran shares his story. Novartis.com/careers
Novartis is delighted to be included on the Forbes World’s Best Employers 2021 list, but what makes this recognition so important is it’s based on the feedback of our associates. At Novartis, we value our associates. It is our associates who challenge medical paradigms and deliver transformative innovation, who spark digital revolution, who support patients, caregivers and healthcare providers and who collaborate and work with integrity, and we will continue to create a culture and people experience worthy of this incredible group of talented people. Novartis.com/careers
Disabilities are a part of being human, and at some point in our lives 15% of us will experience some form of disability. At Novartis, we believe in creating a diverse, equitable and inclusive environment where each of us is empowered and supported to be our whole selves every day. https://www.novartis.com/about/diversity-inclusion
Novartis is delighted to be ranked #3 by the Association of Talent Developers (ATD) in the ATD BEST Awards, one of the industry’s most rigorous and coveted accolades. At Novartis, we support our culture of curiosity and strive to provide our associates with best-in-class learning opportunities for personal and professional growth. Only by unleashing the power and curiosity of our people can we continue with our journey to develop innovative medicines to improve and extend people’s lives across the globe. Imagine your learning experience here at Novartis! Novartis.com/careers
Size matters! Imagine working with 5600 scientists across 6 research campuses collaborating on breakthrough therapies using best in class technology. Working with industry partners in an environment where you can still get published. Speed matters too...! Getting breakthrough medicines to patients quickly at scale can only be achieved in a large scale best in class company but not so fast that we lose scientific rigor! Have we triggered your curiosity? Meet the beating heart of Novartis, the Novartis Institutes for BioMedical Research (NIBR), and start your conversation with us today. Novartis.com/careers
Addressing inequity in healthcare calls for a holistic approach to embedding D&I across the clinical development ecosystem. John Tsai, Novartis’ Head of Global Drug Development and Chief Medical Officer, shares the Novartis commitment to diversity in clinical trials with the long-term view to leveraging data and digital, building strategic partnerships and remodeling our processes and tools to create sustainable change.
At 16 Patrice Matchaba became a war refugee. He grew up in a country where racism was legal and society was segregated. He went on to practice medicine in Africa and in 2000 he joined Novartis to run multiple drug development programs. Now, Patrice has a vision...
